The antioxidative effect of oligomeric procyanidins on neutrophil extracellular traps alleviate chemotherapy-induced chronic kidney injury via gut-kidney axis
Yaqi LuaniD, Weiwei HeiD, Kunmao Jiang, Shenghui Qiu, Lan JiniD, Xinrui Mao, Ying HuangiD, Wentao LiuiD, Jingyuan Cao, Lai JiniD, Rong WangiD
Abstract
Cisplatin is one of the most widely used chemotherapeutic agents for various solid tumors in the clinic, but its use is limited by adverse effects in normal tissues. In particular, cisplatin administration often damages the kidneys. However, little is known about how to alleviate cisplatin-induced chronic kidney disease (CKD) specifically. Here, we found that repeated low-dose cisplatin (RLDC) recruited susceptible neutrophils to the proximal tubule, thereby promoting the progression of CKD in the mouse model. Mechanically, cisplatin destroyed the intestinal epithelium, which induced dysregulation of gut flora and intestinal leakage. Under the dual stimulation of intestinal bacteria and cisplatin, neutrophils become extremely susceptible to form Neutrophil extracellular traps (NETs), accumulating in the proximal tubule and promoted chronic inflammation, fibrosis, and chronic hypoxia, leading to poor regeneration that promoted CKD progression. NETs provided a scaffold for tissue factors (TF) adhesion and metalloid-matrix protease 9 (MMP-9) activation, which triggered local ischemia and hypoxia. In addition, NETs promoted inflammasome construction through NOD-like receptor thermal protein domain associated protein 3 (NLRP3) shear and secretion of mature interleukin-18 (IL18), which subsequently released interferon- {gamma} (IFN-{gamma}), contributing to renal interstitial fibrosis. We proposed that oligomeric procyanidins (OPCs) ameliorated RLDC-induced CKD through multi-targeting damage induced by NETs. OPCs ameliorated microcirculatory disorders and inhibited inflammation by protecting the intestinal mucosa barrier and subsequent bacterial endotoxin translocation. Furthermore, we found that OPCs altered the susceptibility of neutrophils to form NETs. In summary, OPC alleviates CKD by inhibiting NETs production via TF/MMP-9 and IL-18-NLRP3 pathways. OPCs protect the kidney through anti-inflammatory and antioxidant activities, and restore the balance of the intestinal flora.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The IQGAP1-Claudin Cell Junction Axis in Cisplatin-induced Kidney Damage
Yusuf Barudi, Xiuzhen Fan, … Mahasin A. Osman·Cell Communication and SignalingPeer-reviewed·Mar 24, 2026
- SPIRONOLACTONE BUT NOT EPLERENONE EXACERBATES CISPLATIN NEPHROTOXICITY
G. Estrela, B. Bonnard, … F. Jaisser·bioRxiv·Oct 2, 2019
- Naringenin Attenuates Cisplatin-Induced Hepatotoxicity and Nephrotoxicity by Restoring Glutathione Homeostasis and Suppressing Lipid Peroxidation in a Murine Model
Ashwin Dev, Kamalesh Dattaram Mumbrekar·bioRxiv·Apr 24, 2026
- Edaravone-Loaded Mesoscale Nanoparticles Treat Cisplatin-Induced Acute Kidney Injury
R. M. Williams, J. Shah, … D. A. Heller·bioRxiv·Jan 24, 2020
- Macrophage Depletion Protects Against Cisplatin-Induced Ototoxicity and Nephrotoxicity
C. Y. W. Sung, N. Hayase, … L. L. Cunningham·bioRxiv·Nov 16, 2023
- Farnesoid X receptor agonism prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease
B. A. Jones, K. Myakala, … M. Levi·bioRxiv·Mar 1, 2023